Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase

Area of Science:

• Biochemistry and Molecular Biology
• Hematology
• Structural Biology

Background:

• Janus kinase-2 (JAK2) is crucial for cytokine signaling, mediating pathways for erythropoietin and growth hormone.
• Mutations in the JAK2 pseudokinase domain are a primary cause of myeloproliferative neoplasms (MPNs).
• The structural basis for JAK2 autoinhibition and the mechanism of pathogenic activation by mutations remain largely unknown.

Purpose of the Study:

• To elucidate the structural mechanism of JAK2 autoinhibition.
• To determine the molecular basis for JAK2 hyperactivity in MPNs.

Main Methods:

• Molecular dynamics simulations of protein-protein docking were employed to model the JAK2 tandem kinase domains.
• Mutagenesis experiments were conducted to validate the structural model.

Main Results:

• A structural model of the autoinhibitory interaction between the JAK2 pseudokinase and kinase domains was generated.
• Nearly all JAK2 mutations linked to MPNs were found to map to the pseudokinase-kinase domain interface.
• The pseudokinase domain stabilizes the kinase domain in an inactive conformation, explaining the hyperactivity of mutations like V617F.

Conclusions:

• The pseudokinase domain plays a critical role in JAK2 autoinhibition.
• The domain interface is a key site for pathogenic JAK2 mutations in MPNs.
• This structural insight provides a molecular rationale for JAK2-driven MPNs and potential therapeutic targets.